FCGR2A and neoplasm: Since tumor-associated antigens can reach much higher expression levels as compared to FcγRs, it is tempting to speculate that cell surface-anchored anti-TNFRSF receptor antibody fusion proteins can even gain higher total activity than FcγR-bound conventional anti-TNFRSF receptor antibodies.